Andrew Ip

13PUBLICATIONS
65CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Disease surveillanceHaematological tumoursPredictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Feb 24, 2026
Real-world outcomes after CAR T versus standard therapy in third-line or later relapsed or refractory follicular lymphoma in the United States.

Philip K Chan, Markqayne Ray, Karl M Kilgore

|Nov 14, 2025
Correlates and Detection of Digital Health Literacy in Patients With Colorectal Carcinoma or Non-Hodgkin Lymphoma: Cross-Sectional Study.

Thomas S Gunning, Amanda Khoudary, Osairys Billini

|Jul 01, 2025
Outcomes of CD19 CAR-T therapy in central nervous system lymphoma: Insights from a multicentre experience.

Giulio Cassanello, Efrat Luttwak, Samantha Brown

|Apr 01, 2025
An inflammatory biomarker signature of response to CAR-T cell therapy in non-Hodgkin lymphoma.

Sandeep S Raj, Teng Fei, Shalev Fried

|Feb 26, 2025
Updates on the Biological Heterogeneity of Mantle Cell Lymphoma.

Andrew Ip, Maciej Kabat, Lindsay Fogel

|Feb 01, 2025
Treatment failure patterns in early versus late introduction of CAR T-cell therapy in large B-cell lymphoma.

Magdalena Corona, Andrew Ip, Samantha Brown

Pageof 3

Frequent Collaborators

3 joint publications

Miguel-Angel Perales

3 joint publications

Roni Shouval

2 joint publications

Stuart L Goldberg

2 joint publications

Richard J Lin